SBHIX Holdings — Saratoga Health & Biotechnology Portfolio
Data updated: 2026-07-24
SBHIX holds 29 securities. The top 10 make up 50.7% of net assets, led by Cardinal Health (6.44%) and Jazz Pharmaceuti (6.19%). Health Care (98.5%) and Funds & ETFs (1.5%) are the largest sectors, and 86.1% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.51% of net asset value (99.86% of total assets; remainder is cash and receivables). As of May 31, 2026 · N-PORT.
SBHIX Portfolio Holdings
29 holdings of Saratoga Health & Biotechnology Portfolio by percentage of net assets, from the fund's SEC N-PORT filing as of May 31, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Cardinal Health | CAH | Health Care | 6.44% | $674.83K |
| Jazz Pharmaceuti | JAZZ | Health Care | 6.19% | $648.22K |
| United Therapeut | UTHR | Health Care | 6.17% | $645.91K |
| Amgen, Inc. | AMGN | Health Care | 5.04% | $527.75K |
| Mckesson Corp. | MCK | Health Care | 4.90% | $513.03K |
| Lantheus Holding | LNTH | Health Care | 4.64% | $486.57K |
| Exelixis, Inc. | EXEL | Health Care | 4.55% | $476.78K |
| Novartis AG-ADR | NVS | Health Care | 4.50% | $471.53K |
| Cencora, Inc. | — | Health Care | 4.33% | $453.33K |
| Gilead Sciences | GILD | Health Care | 3.94% | $412.43K |
| Regeneron Pharm | REGN | Health Care | 3.93% | $411.90K |
| Johnson&johnson | JNJ | Health Care | 3.91% | $410.10K |
| Natl Healthcare | NHC | Health Care | 3.72% | $389.50K |
| Merck & Co. | MRK | Health Care | 3.63% | $380.62K |
| The Cigna Group | CI | Health Care | 3.63% | $380.32K |
| Medpace Holdings | MEDP | Health Care | 3.37% | $353.22K |
| Vertex Pharm | VRTX | Health Care | 3.36% | $352.21K |
| Intuitive Surgic | ISRG | Health Care | 3.14% | $329.10K |
| Bristol-Myer Sqb | BMY | Health Care | 3.07% | $321.92K |
| Incyte Corp. | INCY | Health Care | 2.89% | $302.99K |
| Stryker Corp. | SYK | Health Care | 2.40% | $251.70K |
| Medtronic PLC | MDT | Health Care | 2.20% | $230.73K |
| Eli Lilly & Co. | LLY | Health Care | 2.11% | $221.00K |
| Labcorp Holdings | LH | Health Care | 2.11% | $220.79K |
| Elevance Health | ELV | Health Care | 1.63% | $170.25K |
| Ensign Group, Inc. | ENSG | Health Care | 1.60% | $167.48K |
| Dreyfus-Ins-Is | — | Funds & ETFs | 1.56% | $162.98K |
| Novo-Nordisk-ADR | NVO | Health Care | 1.55% | $162.26K |
| Dreyfus Treasury Obligations #0521 | — | Unknown | 0.00% | $0 |
SBHIX Sector Allocation
Saratoga Health & Biotechnology Portfolio holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 98.5% | 27 |
| Funds & ETFs | 1.5% | 1 |
| Unknown | 0.0% | 1 |
SBHIX Country Allocation
Where Saratoga Health & Biotechnology Portfolio's holdings are domiciled, by percentage of net assets (largest 4).
| Country | % of net assets |
|---|---|
| United States | 86.1% |
| Ireland | 8.4% |
| Switzerland | 4.5% |
| Denmark | 1.6% |
SBHIX Portfolio Allocation
Asset-class allocation of Saratoga Health & Biotechnology Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.0% |
| Cash & Equivalents | 1.6% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.